REFRESH LACRI-LUBE- mineral oil, petrolatum ointment 
Allergan, Inc.

----------

REFRESH® LACRI-LUBE®
Drug Facts

Active ingredients

Mineral Oil 42.5%

White Petrolatum 56.8%

Purpose

Eye lubricant

Eye lubricant

Uses

Warnings

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Pull down the lower lid of the affected eye and apply a small amount (one-fourth inch) of ointment to the inside of the eyelid.

Other information

Inactive ingredients

Chlorobutanol and Lanolin alcohols.

Questions or comments?

1.800.678.1605

refreshbrand.com

Principal Display Panel

NDC 0023-0312-04

Lubricant Eye Ointment

Refresh®
LACRI-LUBE®

Nighttime Relief for
Intense Eye Dryness

Net wt. 0.12 oz (3.5 g) Sterile

Principal Display Panel
NDC 0023-0312-04
Lubricant Eye Ointment
Refresh® 
LACRI-LUBE® 

Nighttime Relief for
Intense Eye Dryness

Net wt. 0.12 oz (3.5 g) Sterile

REFRESH LACRI-LUBE 
mineral oil, petrolatum ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-0312
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MINERAL OIL (UNII: T5L8T28FGP) (MINERAL OIL - UNII:T5L8T28FGP) MINERAL OIL425 mg  in 1 g
PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM568 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CHLOROBUTANOL (UNII: HM4YQM8WRC)  
LANOLIN ALCOHOLS (UNII: 884C3FA9HE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-0312-041 in 1 CARTON12/15/1977
13.5 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:0023-0312-071 in 1 CARTON12/15/1977
27 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01812/15/1977
Labeler - Allergan, Inc. (144796497)

Revised: 12/2022
Document Id: fcef5d58-db5e-4350-af53-2d664bb31211
Set id: d232a44b-516d-4cdf-a4e7-c3a9a50dc7af
Version: 7
Effective Time: 20221201
 
Allergan, Inc.